Sunshine Nationwide: Fed Disclosure Law Meets Some, Not All, Industry Goals
This article was originally published in The Gray Sheet
Executive Summary
Device industry representatives say they are happy that the new federal mandate for publicly disclosing payments to physicians includes some pre-emptive authority over states, but they hope to convince lawmakers to strengthen that authority before the new rules take effect
You may also be interested in...
AdvaMed Looks To Leverage U.S. Regs For Global Convergence
The trade group, under its new board chairman José Almeida, plans to push for the relatively new U.S. unique device identifier and Sunshine Act regulations to be the basis of globally harmonized mandates.
Sunshine Reg Finally Rises: Start Date For Physician Payment Data Collection Delayed
Two-and-a-half months late and with only a draft version of the regulations released, CMS is giving device and drug companies, and GPOs, more time to prepare for impending requirements to report physician payments and investment interests to the government for public posting.
Senate Finance Committee Examines Improper Cardiac Stent Implants
The Senate Finance Committee signaled enhanced scrutiny into unnecessary use of stents and other implantable devices in a report released Dec. 6.